Cargando…
Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine
BACKGROUND: There are currently no serum biomarkers capable of distinguishing elevations in serum alanine aminotransferase (ALT) that portend serious liver injury potential from benign elevations such as those occurring during cholestyramine treatment. The aim of the research was to test the hypothe...
Autores principales: | Singhal, Rohit, Harrill, Alison H, Menguy-Vacheron, Francoise, Jayyosi, Zaid, Benzerdjeb, Hadj, Watkins, Paul B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130124/ https://www.ncbi.nlm.nih.gov/pubmed/25086653 http://dx.doi.org/10.1186/2050-6511-15-42 |
Ejemplares similares
-
Gastrointestinal Elimination of Perfluorinated Compounds Using Cholestyramine and Chlorella pyrenoidosa
por: Genuis, Stephen J., et al.
Publicado: (2013) -
Cholestyramine Use for Rapid Reversion to Euthyroid States in Patients with Thyrotoxicosis
por: Ha, Jeonghoon, et al.
Publicado: (2016) -
SAT483 Role of Cholestyramine in Refractory Amiodarone-induced Thyrotoxicosis
por: Zhao, Huaying, et al.
Publicado: (2023) -
Randomized Controlled Trial of Cholestyramine and Hydrotalcite to Eliminate Bile for Capsule Endoscopy
por: Hong-Bin, Chen, et al.
Publicado: (2016) -
Role of Cholestyramine in Refractory Hyperthyroidism: A Case Report and Literature Review
por: Alswat, Khaled A.
Publicado: (2015)